He who laughs first laughs last. These are both good choices as Novartis' division and Teva sell the most Adderall and they both cant produce enough to meet demand. Elite is busy building up inventory for this and future quarters this fiscal year. And then there is the Kirkov connection.
I concur King, I believe most savvy shareholders know that Mikah is the frontrunner to acquire Elite !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!